Sujith K. Joseph, PhD, is a scientist trained in human immunology of prophylactic and therapeutic interventions. With a doctorate focused on understanding immune modulation on human and animal systems, Dr. Joseph continued his research at the University of Illinois (UIC) and the National Institutes of Health (NIH) to identify and optimize vaccine candidates against infectious diseases, based on naturally occurring protective immune responses in endemic populations. The combination of the scientific environment and mentoring he received at these institutions helped him gather the skills, knowledge and ingenuity necessary to further extend his expertise to interrogations in tumor immunotherapy.
Currently, he conducts translational research with gene-modified T-cells for solid tumors in children and young adults within the Center for Cell and Gene Therapy at Baylor College of Medicine. His research focuses on the pre-clinical development of novel Chimeric Antigen Receptor (CAR) molecules and delineating immune responses in patients undergoing CAR T-cell therapy in clinical trials.